CEO and Chairman of BOD, 10% Owner of Pain Therapeutics (PTIE, Financial) Remi Barbier sells 6,576 shares of PTIE on 05/06/2010 at an average price of $5.61 a share.
Pain Therapeutics has a market cap of $240.6 million; its shares were traded at around $5.69 with and P/S ratio of 11.7.
PTIE is in the portfolios of Daniel Loeb of Third Point, LLC, Richard Perry of Perry Capital, Jim Simons of Renaissance Technologies LLC.
Pain Therapeutics has a market cap of $240.6 million; its shares were traded at around $5.69 with and P/S ratio of 11.7.
PTIE is in the portfolios of Daniel Loeb of Third Point, LLC, Richard Perry of Perry Capital, Jim Simons of Renaissance Technologies LLC.
CEO Recent Trades:
- Sell:: CEO and Chairman of BOD, 10% Owner Remi Barbier sold 43,424 shares of PTIE stock on 05/05/2010 at the average price of 5.91, the price of the stock has decreased by 3.72% since.
- Sell:: CEO and Chairman of Board, 10% Owner Remi Barbier sold 5,800 shares of PTIE stock on 04/07/2010 at the average price of 6.23, the price of the stock has decreased by 8.67% since.
- Sell:: CEO & Chairman of the Board, 10% Owner Remi Barbier sold 32,200 shares of PTIE stock on 04/06/2010 at the average price of 6.25, the price of the stock has decreased by 8.96% since.
- Sell:: CEO and Chairman of the Board, 10% Owner Remi Barbier sold 12,000 shares of PTIE stock on 04/01/2010 at the average price of 6.16, the price of the stock has decreased by 7.63% since.
- Sell:: CEO and Chair of Board, 10% Owner Remi Barbier sold 5,443 shares of PTIE stock on 03/03/2010 at the average price of 6.13, the price of the stock has decreased by 7.18% since.
Directors and Officers Recent Trades:
- Sell:: COO Nadav Friedmann sold 15,000 shares of PTIE stock on 05/04/2010 at the average price of 5.95, the price of the stock has decreased by 4.37% since.
- Sell:: Chief Scientific Officer Grant Schoenhard sold 26,500 shares of PTIE stock on 04/16/2010 at the average price of 6.29, the price of the stock has decreased by 9.54% since.
- Sell:: COO Nadav Friedmann sold 15,000 shares of PTIE stock on 04/01/2010 at the average price of 6.17, the price of the stock has decreased by 7.78% since.
- Sell:: Chief Scientific Officer Grant Schoenhard sold 35,000 shares of PTIE stock on 03/16/2010 at the average price of 6.13, the price of the stock has decreased by 7.18% since.
- Sell:: Director Donnell Michael J O sold 25,000 shares of PTIE stock on 03/11/2010 at the average price of 6.14, the price of the stock has decreased by 7.33% since.
